Literature DB >> 15389364

[Validity of the non-mydriatic camera for diabetic retinopathy screening and analysis of retinopathy risk indicators].

M Baeza Díaz1, V Gil Guillén, D Orozco Beltrán, V Pedrera Carbonell, C Ribera Montes, I Pérez Pons, J Martínez-Toldos.   

Abstract

PURPOSE: Analysis of the validity of the non-mydriatic camera in detecting diabetic retinopathy and severity levels which can be referred to the ophthalmologist. Analysis of risk indicators of diabetic retinopathy which help increase the sensitivity of the screening: development time of prolonged diabetes (more than 20 years); poor metabolic control (HbA1C > 10%).
METHOD: A cross-sectional study was designed to determine the validity of a diagnostic test (non-mydriatic fundus camera Topcon model TRC-NW6S). As criteria for evaluation we used validity indicators, predictive values, indicators of clinical use, and concordance.
SETTING: Primary Care. Patients with severe cataracts were excluded. The sample size was 376 eyes of 188 type-2 diabetic patients.
RESULTS: With reference to the distribution of diabetic retinopathy we found that 41.25% had a variable level of retinopathy. The validity indicators analysed improved as the number of fundus fields studied increased, obtaining sensitivity levels of greater than 75%; specificity greater than 95%; positive predictive values greater than 90% and almost perfect concordance when two or three fundus fields were used.
CONCLUSIONS: The analysis of retinal photography in digital format can be considered a valid method with respect to the gold standard, and the severity indicators analysed can play a guiding role in obtaining greater prevalences of derivable diabetic retinopathy, but cannot be used as an isolated test for making clinical decisions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15389364     DOI: 10.4321/s0365-66912004000900005

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  4 in total

1.  [Ophthalmic disease in diabetes mellitus: management from primary health care].

Authors:  María José Sender Palacios; María Vernet Vernet; Miguel Maseras Bové; Antoni Salvador Playà; Laia Pascual Batlle; Juan Carlos Ondategui Parra; Esther Jovell Fernández
Journal:  Aten Primaria       Date:  2010-04-07       Impact factor: 1.137

2.  External validation of cut-off points for foveal thickness taking into account the intraretinal fluid using optical coherence tomography to diagnose diabetic macular oedema.

Authors:  Carmen Hernández-Martínez; Antonio Palazón-Bru; Cesar Azrak; Aída Navarro-Navarro; Manuel Vicente Baeza-Díaz; José Juan Martínez-Toldos; Vicente Francisco Gil-Guillén
Journal:  PeerJ       Date:  2017-10-12       Impact factor: 2.984

3.  Detection of diabetic macular oedema: validation of optical coherence tomography using both foveal thickness and intraretinal fluid.

Authors:  Carmen Hernández-Martínez; Antonio Palazón-Bru; Cesar Azrak; Aída Navarro-Navarro; Manuel Vicente Baeza-Díaz; José Juan Martínez-Toldos; Vicente Francisco Gil-Guillén
Journal:  PeerJ       Date:  2015-11-10       Impact factor: 2.984

4.  Validity of Optical Coherence Tomography as a Diagnostic Method for Diabetic Retinopathy and Diabetic Macular Edema.

Authors:  Cesar Azrak; Manuel Vicente Baeza-Díaz; Antonio Palazón-Bru; Carmen Hernández-Martínez; Aída Navarro-Navarro; José Juan Martínez-Toldos; Vicente Francisco Gil-Guillén
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.